Abstract：
OBJECTIVE: This 2023 updated protocol summarizes the American Association of Clinical Endocrinology\'s (AACE\'s) new framework for the development of clinical practice guidelines and other guidance documents that includes changes to methodology, processes, and policies.
METHODS: AACE has critically reviewed its development processes for guidance documents over the last several years against the National Academy of Medicine Standards for Developing Trustworthy Clinical Practice Guidelines and the Council of Medical Specialty Societies Principles for Development of Specialty Society Clinical Guidelines to determine areas for improvement.
RESULTS: The new AACE framework for development of guidance documents incorporates many changes, including a revised conflicts of interest (COI) policy; strengthened commitment to collection of disclosures and management of relevant COI during development; open calls to membership for authors; new requirements for authors; new diversity, equity, and inclusion (DEI) policy; new empanelment process that incorporates consideration of DEI; and adoption of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to increase the quality of evidence assessment and standardize recommendation grades and statements, among other improvements.
CONCLUSIONS: AACE has revised its policies and adopted a completely new methodology for guideline development in support of the mission to elevate the practice of clinical endocrinology to improve patient care. With the use of an evidence-based medicine framework and by continually assessing and improving its processes for development of guidance, AACE strives to deliver trustworthy, unbiased, and up-to-date information that ensures clinician and patient confidence in AACE content. Further, AACE hopes that these enhancements foster a more collaborative approach to development and increase engagement with the worldwide medical community to improve global health.
METHODS: AACE has critically reviewed its development processes for guidance documents over the last several years against the National Academy of Medicine Standards for Developing Trustworthy Clinical Practice Guidelines and the Council of Medical Specialty Societies Principles for Development of Specialty Society Clinical Guidelines to determine areas for improvement.
RESULTS: The new AACE framework for development of guidance documents incorporates many changes, including a revised conflicts of interest (COI) policy; strengthened commitment to collection of disclosures and management of relevant COI during development; open calls to membership for authors; new requirements for authors; new diversity, equity, and inclusion (DEI) policy; new empanelment process that incorporates consideration of DEI; and adoption of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to increase the quality of evidence assessment and standardize recommendation grades and statements, among other improvements.
CONCLUSIONS: AACE has revised its policies and adopted a completely new methodology for guideline development in support of the mission to elevate the practice of clinical endocrinology to improve patient care. With the use of an evidence-based medicine framework and by continually assessing and improving its processes for development of guidance, AACE strives to deliver trustworthy, unbiased, and up-to-date information that ensures clinician and patient confidence in AACE content. Further, AACE hopes that these enhancements foster a more collaborative approach to development and increase engagement with the worldwide medical community to improve global health.
摘要：
目的：这份2023年更新的协议总结了美国临床内分泌学协会（AACE）制定临床实践指南和其他指导文件的新框架，其中包括对方法的更改。进程,和政策。
方法：AACE在过去几年中根据美国国家医学科学院关于制定值得信赖的临床实践指南的标准和医学专业协会理事会制定专业协会临床指南的原则，严格审查了其指导文件的开发过程，以确定需要改进的领域。
结果：用于制定指导文件的新AACE框架包含了许多变化，包括修订后的利益冲突（COI）政策；在开发过程中加强对相关COI的收集和管理的承诺；公开呼吁作者成员；对作者的新要求；新的多样性，股本，和包容性(DEI)政策；纳入DEI审议的新的委员会进程；以及通过建议评估分级，开发和评估（等级）方法，以提高证据评估的质量并标准化建议等级和声明，在其他改进中。
结论：AACE修订了其政策，并采用了一种全新的指南开发方法，以支持提升临床内分泌学实践以改善患者护理的使命。通过使用循证医学框架，并通过不断评估和改进其制定指南的过程，AACE致力于提供值得信赖的，没有偏见,和最新的信息，以确保临床医生和患者对AACE内容的信心。Further,AACE希望这些增强措施能够促进更多的协作发展方式，并增加与全球医学界的互动，以改善全球健康。
方法：AACE在过去几年中根据美国国家医学科学院关于制定值得信赖的临床实践指南的标准和医学专业协会理事会制定专业协会临床指南的原则，严格审查了其指导文件的开发过程，以确定需要改进的领域。
结果：用于制定指导文件的新AACE框架包含了许多变化，包括修订后的利益冲突（COI）政策；在开发过程中加强对相关COI的收集和管理的承诺；公开呼吁作者成员；对作者的新要求；新的多样性，股本，和包容性(DEI)政策；纳入DEI审议的新的委员会进程；以及通过建议评估分级，开发和评估（等级）方法，以提高证据评估的质量并标准化建议等级和声明，在其他改进中。
结论：AACE修订了其政策，并采用了一种全新的指南开发方法，以支持提升临床内分泌学实践以改善患者护理的使命。通过使用循证医学框架，并通过不断评估和改进其制定指南的过程，AACE致力于提供值得信赖的，没有偏见,和最新的信息，以确保临床医生和患者对AACE内容的信心。Further,AACE希望这些增强措施能够促进更多的协作发展方式，并增加与全球医学界的互动，以改善全球健康。
